Choosing the Right Therapy for Cholesterol

Pharmacy Times interviewed Erin McConnell, PharmD, program manager, pharmacy quality at the University of Pittsburgh Medical Center, on the factors impacting cholesterol treatment management decisions and emerging therapies for high-risk patients.Pharmacy Times: Can you discuss the clinical decision-making process for choosing between statins, PSCK9 inhibitors, or newer agents like inclisiran?McConnell: The cornerstone of therapy is a healthy lifestyle, which includes optimum weight, not…
Read More…

Source: https://www.pharmacytimes.com/view/from-statins-to-psck9-inhibitors-choosing-the-right-therapy-for-cholesterol